Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaNeX: Xenon vs Isoflurane in Partial Nephrectomy
NCT01839084Phase 3Completed
- Sponsor
- RWTH Aachen University
- Start
- Jul 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of xenon in renal cell carcinoma (RCC), sponsored by RWTH Aachen University. Started Jul 2013; status: completed.
02
Drugs
xenon
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01839084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839084.